The Wistar Institute announced today that it has licensed the seed stock for its rubella vaccine to Microgen of Russia for a modest fee in the interest of promoting global public health. The Vishnevskaya-Rostropovich Foundation, headed by renowned cellist Maestro Mstislav Rostropovich, facilitated communication between the organizations in support of the agreement.
Developed in the 1960s at Wistar, the rubella vaccine has eradicated the disease in the
We are pleased to make available the seed stock of our rubella vaccine to the
Congenital rubella syndrome (CRS) is an important cause of severe birth defects. When a woman is infected with the rubella vaccine early in pregnancy, she has a 90 percent chance of passing the virus on to her fetus. The virus can kill the fetus or cause CRS. Although CRS can be a relatively mild disease in children, in fetuses it causes deafness, blindness, mental retardation, and other birth defects.
Scientists at The Wistar Institute began work on the vaccine after a pandemic of rubella swept across
The Vishnevskaya-Rostropovich Foundation encouraged the agreement between Wistar and Microgen and will continue to offer Microgen its assistance as the project moves forward. Established in 1991 by Maestro Rostropovich and his wife, soprano Galina Vishnevskaya, to improve the state of childrens health in
Rubella takes a terrible toll in my native land and other countries, says Rostropovich. I applaud Wistar for providing the vaccine seed stock to Microgen on favorable terms. My foundation is determined to ensure that this vaccine becomes widely available in
The Wistar Institute is an independent nonprofit biomedical research institution dedicated to discovering the causes and cures for major diseases, including cancer, cardiovascular disease, autoimmune disorders, and infectious diseases. Founded in 1892 as the first institution of its kind in the nation, The Wistar Institute today is a
Source: The Wistar Institute